Immune checkpoint inhibitors are a type of cancer treatment that helps the immune system attack cancer cells more effectively. One of the key proteins...
Vous n'êtes pas connecté
In the past two decades, immune checkpoint inhibitors (ICIs) have revolutionised cancer treatment, showing promising results against various solid tumours. This study reviews recent developments in ICIs, focusing on new targets like T cell immunoreceptor with Ig and ITIM domains (TIGIT), T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3), and lymphocyte activation gene-3 (LAG-3). [...]
Immune checkpoint inhibitors are a type of cancer treatment that helps the immune system attack cancer cells more effectively. One of the key proteins...
Immune checkpoint inhibitors are a type of cancer treatment that helps the immune system attack cancer cells more effectively. One of the key proteins...
Immune checkpoint inhibitors are cancer-fighting drugs that help the immune system do its job of detecting and attacking tumour cells. Programmed Cell...
Immune checkpoint inhibitors (ICIs) are a class of immunotherapy that have revolutionized the treatment of cancer.
While immune checkpoint inhibitors (ICIs) can provide lifesaving treatment for patients with cancer, they have also been found to cause immune-related...
While immune checkpoint inhibitors (ICIs) can provide lifesaving treatment for patients with cancer, they have also been found to cause immune-related...
In a new study, clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) have demonstrated the use of exosomes to...
Cold Spring Harbor Laboratory Professor Douglas Fearon discovered that treating pancreatic cancer with a common chemotherapy drug makes immunotherapy...
A new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor therapies work together to recruit new...
A recent study by scientists at the Garvan Institute of Medical Research has uncovered a surprising connection between certain gene variants...